Related Experiment Video
Updated: Jan 24, 2026

Quasistatic Mechanical Testing for Computer-Aided Design and Manufacturing Occlusal Veneers Cemented to Milled Dentin Analog Material
Published on: December 20, 2024
Design of Oxytocin Analogs
1Ferring Research Institute Inc., San Diego, CA, USA. kazimierz.wisniewski@ferring.com.
Abstract:
The neurohypophyseal hormone oxytocin (OT) and related modulators of the oxytocin receptor (OTR) have been the subject of intensive research for nearly seven decades. Despite having rather poor drug-like properties, OT is used as a treatment for labor induction, postpartum hemorrhage, and lactation support. The potential use of OT in the treatment of central nervous system (CNS)-related diseases has recently renewed interest in the pharmacology of OT. Oxytocin is one of the most extensively studied cyclic peptides and since the elucidation of its structure in 1953 thousands of peptidic OT analogs with antagonistic and agonistic properties have been synthesized and biologically evaluated. Among them are atosiban, a mixed oxytocin receptor (OTR)/vasopressin 1a receptor (V1aR) antagonist used as a tocolytic agent approved (in certain countries), and carbetocin, a longer acting OTR agonist on the market for the treatment of postpartum hemorrhage. Many other OT analogs with improved pharmacological properties (e.g., barusiban, Antag III) have been identified. These peptides have been tested in clinical trials and/or used as pharmacological tools. In this chapter, the modifications of the OT molecule that led to the discovery of these compounds are reviewed.
Insights
Oxytocin (OT) research spans decades, leading to analogs like atosiban and carbetocin for labor and hemorrhage. New analogs are being explored for central nervous system (CNS) diseases.
Area of Science:
- Endocrinology
- Neuroscience
- Medicinal Chemistry
Background:
- Oxytocin (OT) is a neurohypophyseal hormone with established uses in obstetrics.
- Despite poor drug-like properties, OT is vital for labor induction, postpartum hemorrhage, and lactation support.
- Recent interest explores OT's potential in treating central nervous system (CNS) diseases.
Purpose of the Study:
- To review modifications of the oxytocin molecule.
- To highlight the discovery of OT analogs with antagonistic and agonistic properties.
- To discuss OT analogs developed for improved pharmacological profiles.
Main Methods:
- Synthesis and biological evaluation of thousands of peptidic OT analogs since 1953.
- Identification of mixed oxytocin receptor (OTR)/vasopressin 1a receptor (V1aR) antagonists (e.g., atosiban).
- Development of longer-acting OTR agonists (e.g., carbetocin) and other improved analogs (e.g., barusiban).
Main Results:
- Discovery of numerous OT analogs with diverse pharmacological properties.
- Atosiban approved as a tocolytic agent in some countries.
- Carbetocin is marketed for postpartum hemorrhage treatment.
Conclusions:
- Extensive research has yielded OT analogs with enhanced properties.
- These analogs serve as valuable therapeutic agents and pharmacological tools.
- Ongoing research continues to explore OT analogs for CNS applications.
Related Concept Videos
Group Design
Factorial Design
Design Example: Designing a Residential Plumbing System
Design Example: Designing Water Slide
Bernoulli's principle determines the water's velocity along the slide....
Design Example: Design of an Irrigation Channel
Design Example

